Literature DB >> 10931962

Immunoactive cannabinoids: therapeutic prospects for marijuana constituents.

S E Straus1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931962      PMCID: PMC34030          DOI: 10.1073/pnas.180314297

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  15 in total

Review 1.  Anti-cytokine therapy for rheumatoid arthritis.

Authors:  R N Maini; P C Taylor
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

2.  Marijuana use and increased risk of squamous cell carcinoma of the head and neck.

Authors:  Z F Zhang; H Morgenstern; M R Spitz; D P Tashkin; G P Yu; J R Marshall; T C Hsu; S P Schantz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-12       Impact factor: 4.254

Review 3.  Marihuana chemistry.

Authors:  R Mechoulam
Journal:  Science       Date:  1970-06-05       Impact factor: 47.728

Review 4.  The relationship between infliximab treatment and lymphoma in Crohn's disease.

Authors:  S J Bickston; G R Lichtenstein; K O Arseneau; R B Cohen; F Cominelli
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

5.  The embryotoxic effects of cannabinoids in rats and mice.

Authors:  R W Fleischman; R H Naqvi; H Rosenkrantz; D W Hayden
Journal:  J Environ Pathol Toxicol       Date:  1980-08

6.  The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.

Authors:  A M Malfait; R Gallily; P F Sumariwalla; A S Malik; E Andreakos; R Mechoulam; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 7.  Discovery and characterization of endogenous cannabinoids.

Authors:  B R Martin; R Mechoulam; R K Razdan
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

8.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

Authors:  D M Eisenberg; R B Davis; S L Ettner; S Appel; S Wilkey; M Van Rompay; R C Kessler
Journal:  JAMA       Date:  1998-11-11       Impact factor: 56.272

Review 9.  Marijuana, immunity and infection.

Authors:  T W Klein; H Friedman; S Specter
Journal:  J Neuroimmunol       Date:  1998-03-15       Impact factor: 3.478

10.  Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells.

Authors:  M D Srivastava; B I Srivastava; B Brouhard
Journal:  Immunopharmacology       Date:  1998-11
View more
  5 in total

1.  Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.

Authors:  T Bisogno; L Hanus; L De Petrocellis; S Tchilibon; D E Ponde; I Brandi; A S Moriello; J B Davis; R Mechoulam; V Di Marzo
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

2.  N-acylethanolamine signaling in tobacco is mediated by a membrane-associated, high-affinity binding protein.

Authors:  Swati Tripathy; Kathryn Kleppinger-Sparace; Richard A Dixon; Kent D Chapman
Journal:  Plant Physiol       Date:  2003-04       Impact factor: 8.340

Review 3.  Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.

Authors:  Rupal Pandey; Venkatesh L Hegde; Narendra P Singh; Lorne Hofseth; Uday Singh; Swapan Ray; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Vitam Horm       Date:  2009       Impact factor: 3.421

4.  Variability in medical marijuana laws in the United States.

Authors:  Jessica Bestrashniy; Ken C Winters
Journal:  Psychol Addict Behav       Date:  2015-09

Review 5.  Cannabidiol: A Brief Review of Its Therapeutic and Pharmacologic Efficacy in the Management of Joint Disease.

Authors:  Charles A Gusho; Tannor Court
Journal:  Cureus       Date:  2020-03-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.